Advancing NASH Research with Mice: Best Practices and Applications of Westernized Diets
ON-DEMAND VIRTUAL SYMPOSIUM
Bioactive Lipids in NASH Pathogenesis
Taconic Biosciences was joined by Dr. Harmeet Malhi as a featured speaker at the virtual NASH Symposium.
Nonalcoholic fatty liver disease (NAFLD) is a complex spectrum of disorders ranging from simple benign steatosis to steatohepatitis (NASH) with fibrosis. NAFLD is increasingly common around the world, especially in Western nations.
In this presentation, you will get a better understanding on the various classes of lipids that may mediate toxicity and identify actionable signaling pathways that may be therapeutic targets in NASH.
Dr. Harmeet Malhi presents on related extracellular Vesicles (EVs), emerging mediators of intercellular communication in NASH.
Complete this form to watch the full presentation.
Harmeet Malhi, MBBS
Professor of Medicine and Physiology, Mayo Clinic
Dr. Malhi currently serves as a deputy editor for Hepatology and on the editorial board of Hepatology Communications. She has published over 90 peer-reviewed manuscripts, editorials and book chapters and has served as a reviewer for numerous journals, including Hepatology and the Journal of Lipid Research.
Dr. Malhi is the principal investigator of two NIH grants and several foundation grants. She is on study section for the American Liver Foundation, AGA, AASLD, and a standing member of Hepatobiliary Pathophysiology study section of the Center for Scientific Review, NIH. Intramurally, she serves as Associate Chair for Research in the Division.